E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia

• Status: Completed
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Be diagnosed with schizophrenia

• Be in stable medical condition (DSM-V)

• report smoking ≥10 tobacco cigarettes/day

• present a breath CO ≥10 ppm

• report wanting to reduce their cigarette smoking

• be fluent in English

• have a stable living situation

Exclusion Criteria:

• be currently pregnant or breastfeeding

• report wanting to quit smoking in the immediate future

• test positive for illicit drugs except THC

• have any illness, medical condition, or use of medications, which in the opinion of the study physicians would preclude safe and/or successful completion of the study